Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fed Conditions
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
An open-label, balanced, randomized, two-treatment, two-period, two sequence, single dose,
crossover, bioequivalence study of Mycophenolate mofetil 250 mg Capsule of Dr. Reddy's
Laboratories limited, comparing with that of Cellcept 250 mg Capsule of Roche Laboratories in
healthy, adult, human, male subjects under fed conditions.